Eli Lilly and Company Diabetes, Kick off Summer With 9th Annua...

Shares of Transition Therapeutics Inc (USA)(NASDAQ:TTHI) opened at $3.55 with 24.80 million outstanding shares and touched its highest price of $3.80 during the day and then finished at $3.54 by scoring +0.85%. In the whole session, it traded on ...

Eli Lilly & Co. (LLY)'s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug. The two patients, given intramuscular injections of Zyprexa ...

I ate egg salad sandwiches with my Grandma Lilly at various local department store tea rooms a mountain of years ago. I love them still, though the kind I build today look a lot less trimmed, pale and polished. They are open-faced, perhaps with a ...

(Comtex SmarTrend(R)) Shares of Eli Lilly (NYSE:LLY) have bearishly opened below the pivot of $52.54 today and have reached the first support level of $52.02. Investors may be interested in a cross of the next downside pivot targets of $51.69 and ...

The FDA said in a safety announcement on its website that it is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa. The patients died 3-4 days after receiving an appropriate ...

StreetInsider.com - Form 4 LILLY ELI & CO For: Jun 17 Filed by: Conterno

Biopharmaceutical company Transition Therapeutics Inc (NASDAQ:TTHI) (TSX:TTH) stated on Monday that Eli Lilly and Company has exercised its option to assume all development and commercialisation rights to TT-401. Eli Lilly and Company will pay a ...

Novartis drug Jakavi improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease Jakavi reduced